* MannKind Corp MNKD.OQ reported quarterly breakeven
results
per share for the quarter ended in December, higher than the
same quarter last year, when the company reported EPS of -7
cents. The mean expectation of six analysts for the quarter was
for breakeven results per share. Wall Street expected results to
range from -2 cents to 4 cents per share.
* Revenue rose 62.2% to $58.47 million from a year ago;
analysts
expected $53.58 million.
* MannKind Corp's reported EPS for the quarter was breakeven
results.
* The company reported quarterly net income of $1.4 million.
* MannKind Corp shares had fallen by 1.6% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 47.4%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for MannKind Corp is
$6.75
This summary was machine generated from LSEG data February 27 at
10:42 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 0.00 0.00 Met
Sep. 30 2023 -0.02 0.01 Beat
Jun. 30 2023 -0.04 -0.02 Beat
Mar. 31 2023 -0.05 -0.04 Beat